If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

COMMENTARY Cell Transplantation for Parkinson's Disease

$79.00 plus tax (Refund Policy)

Buy Article:

Abstract:

Hype is a funny thing. It makes for great airplay and print. Although it is usually intended to boost visibility or awareness, hype is a doubled-edge sword. The short-lived benefits frequently give way to long-term and unintended deleterious effects. The reason is simple. Reality and even fantasy can never really live up to its own hype. Anything short of what the hype promised gives way to a pronouncement of failure. When you think about it, some of the greatest people and events of the last 100 years couldn't live up to the hype that surrounded them. Elvis, the Super Bowl, the search for Al Capone's grave, dot.com companies, the Titanic, and even King Kong were ultimately victims of overreaching hype.

Document Type: Miscellaneous

DOI: http://dx.doi.org/10.0000/096020198389726

Affiliations: Alkermes, Inc., 64 Sidney Street, Cambridge, MA 02139

Publication date: January 1, 2002

More about this publication?
  • Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more